<DOC>
	<DOCNO>NCT00399425</DOCNO>
	<brief_summary>To assess efficacy bemiparin ( low molecular weight heparin ) 3 month treatment chronic foot ulcer diabetic patient .</brief_summary>
	<brief_title>Efficacy Low-Molecular-Weight Heparin ( Bemiparin ) Treatment Chronic Foot Ulcers Diabetic Patients</brief_title>
	<detailed_description>The involvement microcirculation diabetes microangiopathy may cause ulceration severe incapacitation . Torpid ulcer low limb affect 15 % diabetic patient moment lifetime ; one-third patient develop ulcer never achieve definitive cure , half die within three year . Heparins , besides well know antithrombotic effect , show stimulate synthesis heparan sulphate —a potent endogenous anticoagulant— endothelial cell culture proliferation fibroblast take diabetic ulcer . After notice highly positive evolution chronic ulcer six diabetic patient receive LMWHs home prophylaxis deep vein thrombosis , consider excellent safety record drug , decide explore effect LMWHs evolution diabetic foot ulcer quality life diabetic patient see primary care practice . Comparison : bemiparin v placebo</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Diabetic Angiopathies</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>age 18 year ; type I II diabetes mellitus diagnose ( ADA 1998 ) 3 year ; presence least one cutaneous ulcer distal knee , involve deep tissue ( stage I II Wagner ’ classification ) exist least three month ; give write informed consent . hypersensibility heparin pig derivative body weight low 35 kg presence clinical sign infection resolve spite oral antibiotic ; anticoagulant therapy ; severe impairment renal hepatic function ; bleed disorder ; active peptic ulcer ; arterial hypertension poor control ; pregnancy lactation ; terminal illness prognosis survival three month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Heparin , Low-Molecular-Weight</keyword>
	<keyword>Bemiparin</keyword>
	<keyword>Foot Ulcer , Diabetic</keyword>
	<keyword>Diabetic Angiopathies</keyword>
	<keyword>Primary Health Care</keyword>
</DOC>